BACKGROUND: Cirrhotic Cardiomyopathy is a relatively ill-characterized
condition, which is often under-diagnosed due to absence of defined diagnostic
criteria. ECG showing corrected QT Interval prolongation is the most suitable
available option for diagnosis of this condition. OBJECTIVE: To determine the
frequency of corrected QT interval prolongation in patients with liver
cirrhosis. METHODOLOGY: Patients (n=166) with confirmed cirrhosis, 30 years or older, presented in the
outpatient and emergency department of medicine at Capital Hospital Islamabad
between 1 October 2011 and 30 September 2012, were enrolled in this
cross-sectional study after taking consent. ECG was done using calibrated ECG
machine, and the QT Interval was measured. Corrected QT was calculated using
Bazett’s formula and a QTc of more than 0.44 seconds was considered as being
prolonged. RESULTS: The mean age of the patients was 57.05 ± 12.03 years. The
corrected QT Interval varied from 337 ms to 560 ms. The mean QTc Interval was
429.92 ms ± 45.11. QTc was prolonged in 41 out of 166 patients (24.7%).
Frequency of QTc prolongation was 4.5% in Child Pugh Grade A, 23.2% in Child Pugh Grade B, and 32.0% in Child Pugh
Grade C. Association of Child Pugh Scoring with QTc prolongation was determined
and found to be statistically significant (P < 0.05). CONCLUSION: QTc
interval was prolonged in 24.7% of cirrhotic patients in our study. There was a
significant increase in frequency with worsening of Child Pugh Grade, thereby
indicating an association between QTc prolongation and the severity of
cirrhosis.
References
[1]
Heidelbaugh, J.J. and Bruderly, M. (2006) Cirrhosis and Chronic Liver Failure: Part I. Diagnosis and Evaluation. American Family Physician, 74, 756-62.
[2]
Stroffolini, T., Sagnelli, E., Almasio, P., et al. (2004) Characteristics of Liver Cirrhosis in Italy: Results from a Multicenter National Study. Digestive and Liver Disease, 36, 56-60. http://dx.doi.org/10.1016/j.dld.2003.07.007
[3]
Anderson, R.N. And Smith, B.L. (2003) Deaths: Leading Causes for 2001. National Vital Statistics Reports, 52, 1-85.
[4]
Haliday, M.L., Coates, R.A. and Rankin, J.G. (1991) Changing Trends of Cirrhosis Mortality in Ontario, Canada 1911-1986. International Journal of Epidemiology, 20, 199-208. http://dx.doi.org/10.1093/ije/20.1.199
[5]
Kowalski, H.J. and Abelmann, W.H. (1953) The Cardiac Output at Rest in Laennec’s Cirrhosis. Journal of Clinical Investigation, 32, 1025-1033. http://dx.doi.org/10.1172/JCI102813
[6]
Abelmann, W.H., Kowalski, H.J. and McNeely, W.F. (1955) The Hemodynamic Response to Exercise in Patients with Laennec’s Cirrhosis. Journal of Clinical Investigation, 34, 690-695. http://dx.doi.org/10.1172/JCI103120
[7]
Zuberi, B.F., Ahmed, S., Faisal, N., et al. (2007) Comparison of Heart Rate and QTc Duration in Patients of Cirrhosis of Liver with Non-Cirrhotic Controls. Journal of the College of Physicians and Surgeons Pakistan, 17, 69-71.
[8]
Chugh, S.S., Reinier, K., Singh, T., et al. (2009) Determinants of prolonged QT Interval and Their Contribution to Sudden Death Risk in Coronary Artery Disease: The Oregon Sudden Unexpected Death Study. Circulation, 119, 663-670. http://dx.doi.org/10.1161/CIRCULATIONAHA.108.797035
[9]
Bernardi, M., Calandra, S., Colantoni, A., et al. (1998) Q-T Interval Prolongation in Cirrhosis: Prevalence, Relationship with Severity, and Etiology of the Disease and Possible Pathogenetic Factors. Hepatology, 27, 28-34. http://dx.doi.org/10.1002/hep.510270106
[10]
Walsh, K. and Alexander, G.J. (2001) Update on Chronic Viral Hepatitis. Postgraduate Medical Journal, 77, 498-505. http://dx.doi.org/10.1136/pmj.77.910.498
[11]
Smedsrod, B., Pertoft, H., Gustafson, S., et al. (1990) Scavenger Functions of the Liver Endothelial Cell. Biochemical Journal, 266, 313-327.
[12]
Ripoll, C., Catalina, M.V., Yotti, R., et al. (2008) Cardiac Dysfunction during Liver Transplantation: Incidence and Preoperative Predictors. Transplantation, 85, 1766-1772. http://dx.doi.org/10.1097/TP.0b013e318172c936
[13]
Alqahtani, S.A., Fouad, T.R. and Lee, S.S. (2008) Cirrhotic Cardiomyopathy. Seminars in Liver Disease, 28, 59-69. http://dx.doi.org/10.1055/s-2008-1040321
[14]
Jessup, M., Abraham, W.T., Casey, D.E., et al. (2009) 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration with the International Society for Heart and Lung Transplantation. Journal of the American College of Cardiology, 53, 1343-1382. http://dx.doi.org/10.1016/j.jacc.2008.11.009
[15]
Makkar, R.R., Fromm, B.S., Steinman, R.T., et al. (1993) Female Gender as a Risk Factor for Torsades de Pointes Associated with Cardiovascular Drugs. JAMA, 270, 2590-2597. http://dx.doi.org/10.1001/jama.1993.03510210076031
[16]
Li, L., Liu, H.R., Shu, J.L., et al. (2007) Clinical Investigation of Q-T Prolongation in Hepatic Cirrhosis. Zhonghua Yi Xue Za Zhi, 87, 2717-2718.
[17]
Bal, J.S. and Thuluvath, P.J. (2003) Prolongation of QTc Interval: Relationship with Etiology and Severity of Liver Disease, Mortality and Liver Transplantation. Liver International, 23, 243-248. http://dx.doi.org/10.1034/j.1600-0676.2003.00833.x
[18]
Kosar, F., Ates, F., Sahin, I., et al. (2007) QT Interval Analysis in Patients with Chronic Liver Disease: A Prospective Study. Angiology, 58, 218-24. http://dx.doi.org/10.1177/0003319707300368